403
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Associations of nailfold capillary abnormalities and immunological markers in early Raynaud’s phenomenon

, , , , , , , , & show all
Pages 226-233 | Accepted 17 Sep 2013, Published online: 12 Feb 2014

References

  • Block JA, Sequeira W. Raynaud’s phenomenon. Lancet 2001; 357:2042–8.
  • Goundry B, Bell L, Langtree M, Moorthy A. Diagnosis and management of Raynaud’s phenomenon. Br Med J 2012;344:e289.
  • Grassi W, De Angelis R, Lapadula G, Leardini G, Scarpa R. Clinical diagnosis found in patients with Raynaud’s phenomenon: a multicentre study. Rheumatol Int 1998;18:17–20.
  • Belch JJ. Raynaud’s phenomenon. Curr Opin Rheumatol 1991; 3:960–6.
  • Rosato E, Molinaro I, Rossi C, Pisarri S, Salsano F. The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud’s phenomenon. Scand J Rheumatol 2011;40:292–8.
  • LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–8.
  • Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988;47:634–41.
  • Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud’s phenomenon. Rheum Dis Clin North Am 1990;16:11–30.
  • Ingegnoli F, Boracchi P, Gualtierotti R, Biganzoli EM, Zeni S, Lubatti C, et al. Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford) 2010;49:479–805.
  • Wollersheim H, Thien T, Hoet MH, Van Venrooy WJ. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud’s phenomenon. Eur J Clin Invest 1989;19:535–41.
  • Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990;16:75–91.
  • Cutolo M, Pizzorni C, Sulli A. Capillaroscopy.Best Pract Res Clin Rheumatol 2005;19: 437–52.
  • Cutolo M, Pizzorni C, Tuccio M, Burroni, A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004;43:719–26.
  • Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902–12.
  • Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 2002;11:35–41.
  • Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR. Predictive value of nailfold capillaroscopy in patients with Raynaud’s phenomenon. Clin Rheumatol 2006;25:153–8.
  • Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981;24:1159–65.
  • Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986;13:556–63.
  • Sander O, Sunderkötter C, Kötter I, Wagner I, Becker M, Herrgott I, et al. Capillaroscopy. Procedure and nomenclature. Z Rheumatol 2010;69:253–62.
  • Carpentier PH, Franco A. Atlas of capillary microscopy, vol. 1. Wiesbaden: Abbott GmbH, 1983.
  • Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996;55:507–12.
  • Riccieri V, Spadaro A, Ceccarelli F, Scrivo R, Germano V, Valesini G. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 2005;14:521–5.
  • Ingegnoli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F. Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 2005;11:295–8.
  • Caspary L, Schmees C, Schoetensack I, Schoetensack I, Hartung K, Stannat S, et al. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. J Rheumatol 1991;18:559–66.
  • Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67:885–7.
  • Villalta D, Imbastaro T, Di Giovanni S, Lauriti C, Gabini M, Turi MC, et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 2012;12:114–20.
  • Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci D, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002;4:R11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.